AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 79 filers reported holding AKEBIA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,339 | -85.2% | 1,175 | -88.1% | 0.00% | – |
| Q2 2023 | $9,030 | +69361.5% | 9,869 | -56.9% | 0.00% | – |
| Q1 2023 | $13 | +30.0% | 22,896 | +33.0% | 0.00% | – |
| Q4 2022 | $10 | -99.9% | 17,211 | -54.5% | 0.00% | – |
| Q3 2022 | $12,000 | -14.3% | 37,823 | -4.1% | 0.00% | – |
| Q2 2022 | $14,000 | -65.9% | 39,433 | -30.9% | 0.00% | – |
| Q1 2022 | $41,000 | -76.7% | 57,058 | -26.6% | 0.00% | -100.0% |
| Q4 2021 | $176,000 | +85.3% | 77,782 | +135.6% | 0.00% | +50.0% |
| Q3 2021 | $95,000 | +58.3% | 33,009 | +108.0% | 0.00% | 0.0% |
| Q2 2021 | $60,000 | -14.3% | 15,867 | -23.7% | 0.00% | +100.0% |
| Q1 2021 | $70,000 | +84.2% | 20,804 | +50.6% | 0.00% | 0.0% |
| Q4 2020 | $38,000 | -91.0% | 13,817 | -91.8% | 0.00% | -80.0% |
| Q3 2020 | $422,000 | +11.3% | 168,320 | +502.6% | 0.01% | -68.8% |
| Q2 2020 | $379,000 | +37800.0% | 27,934 | +27834.0% | 0.02% | – |
| Q1 2020 | $1,000 | 0.0% | 100 | -20.0% | 0.00% | – |
| Q4 2019 | $1,000 | -96.7% | 125 | -98.4% | 0.00% | -100.0% |
| Q3 2019 | $30,000 | +900.0% | 7,767 | +1901.8% | 0.00% | – |
| Q1 2019 | $3,000 | 0.0% | 388 | -22.7% | 0.00% | – |
| Q4 2018 | $3,000 | -89.3% | 502 | -82.8% | 0.00% | -100.0% |
| Q1 2018 | $28,000 | +64.7% | 2,920 | +148.3% | 0.00% | 0.0% |
| Q4 2017 | $17,000 | -41.4% | 1,176 | -20.2% | 0.00% | 0.0% |
| Q3 2017 | $29,000 | -14.7% | 1,474 | -37.6% | 0.00% | -50.0% |
| Q2 2017 | $34,000 | +112.5% | 2,364 | +58.3% | 0.00% | +100.0% |
| Q4 2016 | $16,000 | +100.0% | 1,493 | +69.5% | 0.00% | +100.0% |
| Q3 2016 | $8,000 | +14.3% | 881 | -1.9% | 0.00% | 0.0% |
| Q2 2016 | $7,000 | -68.2% | 898 | -63.6% | 0.00% | -66.7% |
| Q1 2016 | $22,000 | +15.8% | 2,469 | +64.6% | 0.00% | 0.0% |
| Q4 2015 | $19,000 | -34.5% | 1,500 | -50.5% | 0.00% | 0.0% |
| Q3 2015 | $29,000 | +81.2% | 3,031 | +109.6% | 0.00% | +50.0% |
| Q1 2015 | $16,000 | +23.1% | 1,446 | +24.8% | 0.00% | +100.0% |
| Q4 2014 | $13,000 | – | 1,159 | – | 0.00% | – |
| Q3 2014 | $0 | -100.0% | 0 | -100.0% | 0.00% | -100.0% |
| Q2 2014 | $46,000 | – | 1,645 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 4,652,561 | $13,027,000 | 5.13% |
| Orchard Capital Management, LLC | 857,138 | $2,400,000 | 1.02% |
| Nantahala Capital Management | 7,040,487 | $19,713,000 | 0.61% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 209,040 | $585,000 | 0.18% |
| Woodline Partners LP | 2,382,522 | $6,671,000 | 0.18% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,546,169 | $4,329,000 | 0.15% |
| Virtus ETF Advisers LLC | 92,771 | $260,000 | 0.11% |
| Jump Financial, LLC | 155,583 | $435,000 | 0.07% |
| GSA CAPITAL PARTNERS LLP | 128,626 | $360,000 | 0.06% |
| Anson Funds Management LP | 95,342 | $267,000 | 0.05% |